Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Patients receiving vitamin D demonstrated significantly longer TFS compared with nonusers (median 147 vs. 82 months, p <0.001).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Patients were followed from diagnosis until initiation of the first CLL‐directed therapy or censoring.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D Supplementation and Treatment‐Free Survival in Early‐Stage CLL: A Real‐World Validation Study
Study design awaiting verification · EJHaem · 2026
Original publication title
Vitamin D Supplementation and Treatment‐Free Survival in Early‐Stage CLL: A Real‐World Validation Study
© 2026 The Author(s). eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Patients with early‐stage chronic lymphocytic leukemia (CLL) are typically managed with a watch‐and‐wait strategy, and no intervention has been shown to modify the natural history of the disease.
Source: BackgroundAbstract: What methods does the paper describe?
We analyzed a large real‐world cohort derived from Clalit Health Services, including patients diagnosed with early‐stage CLL between 2000 and 2022 who were initially managed with active surveillance. Exposure was defined as vitamin D supplementation for at least 6 months during the watch‐and‐wait period. The primary endpoint was treatment‐free survival (TFS). Multivariable time‐dependent Cox models and inverse probability of treatment weighting were applied to adjust for baseline differences.
Source: MethodsAbstract: Results
The cohort included 5496 patients, of whom 1862 (34%) received vitamin D supplementation. Median age at diagnosis was 72.2 years, and 56% were male. Median follow‐up was 46 months. Patients receiving vitamin D demonstrated significantly longer TFS compared with nonusers (median 147 vs. 82 months, p <0.001). In multivariable time‐dependent Cox analysis adjusted for age, sex, and laboratory parameters, vitamin D exposure remained independently associated with improved TFS (HR: 0.87, 95% CI: 0.75 to 0.99; p = 0.027).
Source: ResultsAbstract: Conclusions
In this large real‐world validation cohort, vitamin D supplementation was associated with prolonged TFS in patients with early‐stage CLL managed with active surveillance.
Source: ConclusionsAuthors’ abstract
ABSTRACT
Background
Patients with early‐stage chronic lymphocytic leukemia (CLL) are typically managed with a watch‐and‐wait strategy, and no intervention has been shown to modify the natural history of the disease.
Methods
We analyzed a large real‐world cohort derived from Clalit Health Services, including patients diagnosed with early‐stage CLL between 2000 and 2022 who were initially managed with active surveillance. Exposure was defined as vitamin D supplementation for at least 6 months during the watch‐and‐wait period. The primary endpoint was treatment‐free survival (TFS). Multivariable time‐dependent Cox models and inverse probability of treatment weighting were applied to adjust for baseline differences.
Results
The cohort included 5496 patients, of whom 1862 (34%) received vitamin D supplementation. Median age at diagnosis was 72.2 years, and 56% were male. Median follow‐up was 46 months. Patients receiving vitamin D demonstrated significantly longer TFS compared with nonusers (median 147 vs. 82 months, p <0.001). In multivariable time‐dependent Cox analysis adjusted for age, sex, and laboratory parameters, vitamin D exposure remained independently associated with improved TFS (HR: 0.87, 95% CI: 0.75 to 0.99; p = 0.027).
Conclusions
In this large real‐world validation cohort, vitamin D supplementation was associated with prolonged TFS in patients with early‐stage CLL managed with active surveillance.
Trial Registration
The authors have confirmed clinical trial registration is not needed for this submission.
Publication and source details
Original title: Vitamin D Supplementation and Treatment‐Free Survival in Early‐Stage CLL: A Real‐World Validation Study
Tamar Tadmor; Ronen Arbel; Talish Razi; Lior Rokach
EJHaem · 2026
© 2026 The Author(s). eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-09T20:20:23.902570+00:00
DOI: 10.1002/jha2.70336 · PMC13325541